RECRUITING

PV Loop and Pulmonary Hypertension

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The right ventricular (RV) systolic function is a key determinant of outcome in patients with pulmonary hypertension and elevated pulmonary vascular resistance. As the pulmonary artery pressure and vascular resistance increase (i.e. RV afterload) in these patients, so does the right ventricular contractility in an attempt to maintain cardiac output. This is response of a ventricle to its afterload is termed ventriculo-arterial (VA) coupling. However, there is a limit to this increase in contractility after which VA uncoupling occurs ultimately leading to decrease cardiac output and right ventricular failure. The accepted gold standard for measurement of VA coupling is the ratio of the end systolic ventricular elastance (Ees) to the end systolic arterial elastance (Ea) measured invasively via high fidelity conductance catheters during cardiac catheterization. In this study, the aim is to devise a non-invasive scoring system that can identify VA uncoupling in patients with elevated pulmonary vascular resistance using echocardiography, cardiac MRI, cardiopulmonary exercise testing and brain natriuretic peptide levels. The hypothesis is that a group of morphologic and functional variables obtained noninvasively can differentiate an RV with VA coupling from that with VA uncoupling.

Official Title

Non-Invasive Evaluation of Right Ventricular - Pulmonary Arterial Coupling in Children With Elevated Pulmonary Vascular Resistance

Quick Facts

Study Start:2020-04-27
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05484596

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:1 Year to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Children 1-21 years of age
  2. * Patients referred for cardiac catheterization for hemodynamic evaluation due to concern for pulmonary hypertension
  3. * Structurally normal heart
  1. * Pulmonary hypertension secondary to pulmonary venous hypertension defined as pulmonary capillary wedge pressure of more than or equal to 15mmHg
  2. * Pulmonary hypertension secondary to mixed pulmonary arterial and venous hypertension
  3. * Patient will be excluded from performing an MRI if they have:
  4. * Patients will be excluded from performing a cardiopulmonary exercise test (CPET) if they are: 1) less than 8 years or 2) unable to follow instructions to run on a treadmill.

Contacts and Locations

Study Contact

Brittany Faanes, MPH, CCRP
CONTACT
612-625-5929
grego318@umn.edu
Jasmine Becerra, BS
CONTACT
415-476-2649
jasmine.becerra@ucsf.edu

Principal Investigator

Gurumurthy Hiremath, MD
PRINCIPAL_INVESTIGATOR
University of Minnesota

Study Locations (Sites)

Pediatric Pulmonary Hypertension Program
San Francisco, California, 94143
United States
University of Minnesota
Minneapolis, Minnesota, 55455
United States

Collaborators and Investigators

Sponsor: Hythem Nawaytou

  • Gurumurthy Hiremath, MD, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-04-27
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2020-04-27
Study Completion Date2025-04-30

Terms related to this study

Keywords Provided by Researchers

  • pulmonary vascular resistance
  • pediatric
  • VA uncoupling

Additional Relevant MeSH Terms

  • Pulmonary Vascular Resistance Abnormality